Skip to main content

Roche’s Half-Year Results 2022

Roche has published it's Half-Year Results for 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 21 July 2022.

Agenda
OverviewSeverin Schwan, CEO Roche Group
Pharmaceuticals DivisionBill Anderson, CEO Roche Pharmaceuticals
Diagnostics DivisionThomas Schinecker, CEO Roche Diagnostics
Financial ResultsAlan Hippe, Chief Financial and IT Officer
Questions and answers

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.